1-6 of 6
Hui Kang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Selinexor-Based Combination Therapy in CNS Lymphoma: A Retrospective Experience

Li Li, Yan Ma, Xiaobo Wang, Zhiming Li, Zhiguang Lin, Qi Zhang, Jay Mei, Jingjing Ma, Xin Gao, Hui Kang, Zhijia Zhao, Hang Yang, Qing Li, Mengxue Zhang, Yingbo Zhou, Bobin Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6301.
https://doi.org/10.1182/blood-2023-184682
Published: 2023
Journal Articles

Investigation of High Dose Cytarabine Plus Zenubrutinib in Relapsed/Refractory Primary Central Nervous System Lymphoma

Zhiguang Lin, Bobin Chen, Jingjing Ma, Yan Ma, Hui Kang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12070.
https://doi.org/10.1182/blood-2022-158730
Published: 2022
Journal Articles

Circulating microRNAs Is a Potential Prognostic Biomarker in Primary Central Nervous System Lymphoma

Yan Ma, Dr, Dina Suolitiken, Bobin Chen, MDPhD, Xiaoping Xu, Hui Kang, Dr, Lin Zhiguang, Dr
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-135966
Published: 2020
Journal Articles

Efficacy and Safety of Pemetrexed Combined with Lenalidomide in the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma

Jingjing Ma, Dr, Bobin Chen, MDPhD, Lin Zhiguang, Dr, Qing Li, Dr, Hui Kang, Dr, Yan Ma, Dr
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-138400
Published: 2020
Journal Articles

Comprehensive Genomic Profiling of Chinese Acute Myeloid Leukemia (AML) with FLT3 ITD Using Ultra Deep Sequencing

Hui Kang, MD, Chen Lijuan, Yubing Xu, Fanxiang Zeng, Huan Tong, Lihua Sun, Jinwei Hu, Yongqi Yue, Gung-wei Chirn, Kai Wang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5262.
https://doi.org/10.1182/blood-2018-99-115631
Published: 2018
Journal Articles

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Guang-Biao Zhou, Hui Kang, Lan Wang, Li Gao, Ping Liu, Jun Xie, Feng-Xiang Zhang, Xiang-Qin Weng, Zhi-Xiang Shen, Jue Chen, Long-Jun Gu, Ming Yan, Dong-Er Zhang, Sai-Juan Chen, Zhen-Yi Wang, Zhu Chen
Journal: Blood
Blood (2006) 109 (8): 3441–3450.
https://doi.org/10.1182/blood-2006-06-032250
Published: 2006
Includes: Supplemental data